Trigilio Jeffrey has filed 19 insider transactions across 2 companies since December 2022.
Most recent transaction: a grant/award of 90000 shares of XOMA Royalty Corp ($XOMA) on March 11, 2026.
Activity breakdown: 0 open-market purchases and 10 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 11, 2026 | XOMA Royalty Corp | $XOMA | Trigilio Jeffrey | Chief Financial Officer | A | Common Stock | 90000 | $0.00 | 90,000.0000 | 18,141,000 | 9999.99% | 0.50% |
| March 11, 2026 | XOMA Royalty Corp | $XOMA | Trigilio Jeffrey | Chief Financial Officer | A | Performance Stock Units | 138462 | $0.00 | 138,462.0000 | 18,141,000 | 9999.99% | 0.76% |
| Jan. 12, 2026 | XOMA Royalty Corp | $XOMA | Trigilio Jeffrey | Chief Financial Officer | A | Performance Stock Units | 30000 | $0.00 | 30,000.0000 | 18,141,000 | 9999.99% | 0.17% |
| Feb. 22, 2024 | Cullinan Therapeutics, Inc. | $CGEM | Trigilio Jeffrey | Chief Financial Officer | A | Common Stock | 50000 | $0.00 | 133,919.0000 | 42,900,083 | 59.58% | 0.12% |
| Feb. 22, 2024 | Cullinan Therapeutics, Inc. | $CGEM | Trigilio Jeffrey | Chief Financial Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 42,900,083 | 9999.99% | 0.23% |
| Dec. 21, 2023 | Cullinan Therapeutics, Inc. | $CGEM | Trigilio Jeffrey | Chief Financial Officer | S | Common Stock | 1920 | $8.50 | 83,919.0000 | 0 | 2.24% | 0.00% |
| Dec. 18, 2023 | Cullinan Therapeutics, Inc. | $CGEM | Trigilio Jeffrey | Chief Financial Officer | S | Common Stock | 398 | $8.22 | 85,839.0000 | 0 | 0.46% | 0.00% |
| Dec. 12, 2023 | Cullinan Therapeutics, Inc. | $CGEM | Trigilio Jeffrey | Chief Financial Officer | S | Common Stock | 1926 | $7.81 | 86,237.0000 | 0 | 2.18% | 0.00% |
| June 30, 2023 | Cullinan Therapeutics, Inc. | $CGEM | Trigilio Jeffrey | Chief Financial Officer | A | Common Stock | 2340 | $9.08 | 88,163.0000 | 0 | 2.73% | 0.00% |
| June 20, 2023 | Cullinan Therapeutics, Inc. | $CGEM | Trigilio Jeffrey | Chief Financial Officer | S | Common Stock | 399 | $12.94 | 85,823.0000 | 0 | 0.46% | 0.00% |
| June 12, 2023 | Cullinan Therapeutics, Inc. | $CGEM | Trigilio Jeffrey | Chief Financial Officer | S | Common Stock | 319 | $13.11 | 86,222.0000 | 0 | 0.37% | 0.00% |
| May 18, 2023 | Cullinan Therapeutics, Inc. | $CGEM | Trigilio Jeffrey | Chief Financial Officer | S | Common Stock | 399 | $8.76 | 86,541.0000 | 0 | 0.46% | 0.00% |
| May 12, 2023 | Cullinan Therapeutics, Inc. | $CGEM | Trigilio Jeffrey | Chief Financial Officer | S | Common Stock | 347 | $8.78 | 86,940.0000 | 0 | 0.40% | 0.00% |
| April 18, 2023 | Cullinan Therapeutics, Inc. | $CGEM | Trigilio Jeffrey | Chief Financial Officer | S | Common Stock | 398 | $10.71 | 87,287.0000 | 0 | 0.45% | 0.00% |
| April 12, 2023 | Cullinan Therapeutics, Inc. | $CGEM | Trigilio Jeffrey | Chief Financial Officer | S | Common Stock | 318 | $10.22 | 87,685.0000 | 0 | 0.36% | 0.00% |
| March 20, 2023 | Cullinan Therapeutics, Inc. | $CGEM | Trigilio Jeffrey | Chief Financial Officer | S | Common Stock | 399 | $11.32 | 88,003.0000 | 0 | 0.45% | 0.00% |
| Feb. 17, 2023 | Cullinan Therapeutics, Inc. | $CGEM | Trigilio Jeffrey | Chief Financial Officer | A | Common Stock | 47000 | $0.00 | 88,402.0000 | 0 | 113.52% | 0.00% |
| Feb. 17, 2023 | Cullinan Therapeutics, Inc. | $CGEM | Trigilio Jeffrey | Chief Financial Officer | A | Stock Option (Right to Buy) | 93500 | $0.00 | 93,500.0000 | 0 | 9999.99% | 0.00% |
| Dec. 30, 2022 | Cullinan Therapeutics, Inc. | $CGEM | Trigilio Jeffrey | Chief Financial Officer | A | Common Stock | 201 | $8.97 | 41,402.0000 | 0 | 0.49% | 0.00% |